MAIA ASSAF: Open Payments
NPI 1871007369 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 49 payments from 9 companies in 2025. Trend: 2023 $1,396 · 2024 $1,622 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $311 |
| Indivior Inc. | 8 | $222 |
| E.R. Squibb & Sons, L.L.C. | 9 | $135 |
| Alkermes, Inc. | 4 | $115 |
| ABBVIE INC. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: SUBLOCADE, ABILIFY MAINTENA, COBENFY, ABILIFY ASIMTUFII, REXULTI, VRAYLAR, ARISTADA, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
